Azelastine hydrochloride

Quick links

Choose a section

Quick links to important sections

Advertisements

Azelastine hydrochloride

Selected form

Advertisements
Advertisements

Treatment option: Rhinitis, Hay Fever

Advertisements

Overview of Azelastine hydrochloride

Quick Facts

Property Description
Active ingredient Azelastine hydrochloride
Form Aqueous solution (nasal spray, eye drops)
Pharmacological class Second-generation H1-receptor antagonist
General purpose Targeted relief of allergic symptoms
Origin Synthetic (Phthalazinone derivative)

Azelastine hydrochloride is a highly recognized synthetic second-generation antihistamine utilized as the active pharmaceutical ingredient in anti-allergic medications. This compound, derived from the phthalazinone chemical structure, is clinically recognized for its effectiveness in counteracting symptoms caused by the body's immune-mediated hypersensitivity reactions. Azelastine maintains an established role in managing conditions like allergic rhinitis and conjunctivitis.


What Type of Medication is Azelastine Hydrochloride?

Azelastine hydrochloride is a synthetic second-generation H1-receptor antagonist, belonging to a class of drugs that selectively block the binding of histamine to its receptors. Pharmacological studies confirm that this drug possesses a crucial dual-action mechanism that differentiates it from simpler antihistamines: it not only blocks histamine but also contributes to mast cell stabilization, which helps limit the initial release of inflammatory mediators. This stabilization of immune cells highlights the compound's capacity to provide a broader anti-allergic benefit compared to older agents.


Composition and Common Drug Forms

The active substance, Azelastine (as the hydrochloride salt), is typically presented as an aqueous solution formulated for topical administration, distinguishing it from common oral tablets. Its most widespread forms are an intranasal nasal spray and an ophthalmic solution (eye drops). This design allows the medication to be applied directly to the affected surfaces. While primarily a single-ingredient product, its chemical profile indicates a potent anti-inflammatory property beyond simple antihistamine action, allowing it to address persistent allergic symptoms effectively.


General Purpose: Targeted Relief for Allergic Reactions

The overall purpose of Azelastine hydrochloride is to provide targeted, rapid relief and help manage the inflammatory processes characteristic of allergic responses. By addressing both the immediate activity of histamine and the broader inflammatory cascade through its dual mechanism, the medication is fundamentally designed to quickly lessen the local symptoms resulting from the body's overreaction to allergens, thereby restoring comfort to the patient experiencing seasonal or perennial allergies.

Advertisements

What side effects are possible with Azelastine hydrochloride?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential adverse reactions of Azelastine hydrochloride to provide a clear regulatory safety profile, primarily focusing on effects at the administration site and systemic reactions common to the antihistamine class. The most frequently documented reaction is dysgeusia (a bitter taste), which is classified as Very Common in regulatory summaries.


Documented Adverse Reactions and Frequencies

The following are examples of adverse reactions listed in official regulatory labeling, organized by incidence:

Classification Examples of Documented Reactions
Very Common Dysgeusia (bitter taste)
Common Headache, Somnolence (drowsiness), Nasal Discomfort, Fatigue
Uncommon Epistaxis (nosebleed), Pharyngolaryngeal pain (sore throat), Nausea

These reactions are also grouped into System-Organ Classes, including Nervous System Disorders (e.g., somnolence, headache) and Respiratory, Thoracic and Mediastinal Disorders (e.g., nasal irritation).


Safety Considerations and Restrictions

The regulatory profile for Azelastine hydrochloride includes specific safety limitations. A key restriction is the potential for additive Central Nervous System (CNS) impairment when used concurrently with alcohol or other CNS depressants. This safety note cautions against engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery, due to the risk of somnolence.

Serious Adverse Reactions officially documented, often from post-marketing reports, include severe immune-mediated reactions such as anaphylactoid reactions and angioedema (swelling). The label also includes Population-Specific Safety Information, noting for instance that the safety and effectiveness in pediatric use vary depending on the patient’s age and the specific formulation.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This information is based on officially documented descriptions of overdose from government regulatory sources and outlines mandated emergency actions.


Documented Overdose Manifestations

Domain Official Regulatory Statements
Documented presentations Overdosage may present as drowsiness, somnolence, or lethargy and potential severe central nervous system (CNS) symptoms [NIH/DailyMed, EMA SmPC].
Physiological systems affected CNS and Cardiovascular System, specifically potential for Tachycardia (fast heart rate) [FDA Label].
Population-specific notes Swallowing the medicine could cause serious harm to a child, necessitating immediate action [NIH/DailyMed].

Immediate Emergency Action Required

Regulatory authorities mandate specific actions for suspected overdose or accidental ingestion. Seek immediate medical attention for any suspected overdose or if the medicine has been accidentally swallowed. It is required to contact a Poison Control Center or get emergency medical help immediately [NIH/DailyMed, FDA Label].

Management and Antidote Information

In cases of overdosage, no specific antidote is known for Azelastine hydrochloride [EMA SmPC]. Management is therefore restricted to symptomatic and supportive treatment. Certain regulatory documents note that measures like administering activated charcoal may be considered for managing acute oral ingestion of large quantities.


The overdose profile is defined by the risk of CNS depression and specific signs like tachycardia. The absence of a specific antidote necessitates the immediate and mandatory action of seeking professional medical care for supportive management.

Advertisements

Therapeutic Uses of Azelastine hydrochloride

Main Uses of Azelastine Hydrochloride

Azelastine hydrochloride is an antihistamine medication primarily used to manage symptoms associated with upper respiratory conditions. It is formulated to provide targeted relief from the physical manifestations of allergic and non-allergic reactions in the nasal passages and eyes.

Allergic Rhinitis

The primary application of azelastine hydrochloride is the treatment of allergic rhinitis. This condition occurs when the immune system overreacts to environmental particles, leading to inflammation of the nasal mucous membranes. It is effective for two specific types:

  • Seasonal Allergic Rhinitis: Often referred to as hay fever, this occurs during specific times of the year in response to outdoor allergens such as pollen from trees, grasses, and weeds.
  • Perennial Allergic Rhinitis: This involves year-round symptoms triggered by indoor allergens, including dust mites, animal dander, and mold.

Vasomotor Rhinitis

Azelastine hydrochloride is also used to treat non-allergic (vasomotor) rhinitis. Unlike allergic rhinitis, this condition is not triggered by the immune system but by environmental factors that cause the blood vessels in the nose to expand. Common triggers include changes in weather, strong odors, or smoke. The medication helps manage the chronic nasal congestion and runny nose associated with this condition.

Allergic Conjunctivitis

In ophthalmic formulations, azelastine hydrochloride is utilized to address allergic conjunctivitis. This condition affects the eyes, causing redness, itching, and watering when an individual is exposed to allergens. The medication works locally to reduce the inflammatory response on the surface of the eye.

Benefits and Mechanism of Action

Azelastine hydrochloride offers several therapeutic benefits for individuals managing respiratory and ocular symptoms:

  • Targeted Relief: As a topical treatment (delivered via nasal spray or eye drops), the medication acts directly on the affected tissues. This localized delivery allows for a rapid onset of action compared to some oral antihistamines.
  • Reduction of Nasal Symptoms: It is particularly effective at reducing sneezing, nasal itching, and clear nasal discharge (rhinorrhea).
  • Management of Congestion: Unlike many first-generation antihistamines, azelastine has shown efficacy in reducing nasal congestion and swelling of the nasal passages.
  • Dual Action: It functions primarily as an H1-receptor antagonist, blocking the effects of histamine—the chemical responsible for most allergy symptoms. Additionally, it may help inhibit the release of other inflammatory mediators from mast cells, providing a broader range of symptom control.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Regulatory documents define population eligibility based on age, formulation, and specific contraindications.

Populations for Whom Use is Restricted or Contraindicated

Classification Rule
Absolute Contraindication Individuals with a known hypersensitivity to Azelastine hydrochloride or any of the product's excipients.
Conditional Avoidance Should not be used to treat contact lens-related irritation (Ophthalmic Solution).
Use Not Recommended Nonprescription (OTC) Nasal Spray is not recommended for children younger than 6 years of age.

Age-Group Eligibility Rules

Formulation/Indication Minimum Age for Established Use Restriction Status
Nasal Spray (SAR) Varies: 2 to 5 years (specific Rx brands) Use not established below minimum age.
Nasal Spray (PAR) Varies: 6 months (specific Rx brands) Use not established below minimum age.
Ophthalmic Solution 3 years and older Safety and efficacy established.

Pregnancy and Lactation Eligibility

Use during pregnancy is advised with caution, as human data is often inadequate; authorization requires the potential benefit to justify the potential risk to the fetus (US FDA Category C for ophthalmic). Caution is recommended during lactation, as the drug is excreted into human milk in small amounts, making use conditional.

Advertisements

What should I know about interactions with other medicines?

Azelastine hydrochloride, particularly when administered as a nasal spray, has several notable interactions, primarily concerning its potential to cause or enhance Central Nervous System (CNS) depression, leading to increased drowsiness, reduced alertness, and impairment of psychomotor skills.

CNS Depressants and Alcohol

Concurrent use of azelastine with alcohol or other CNS depressants should be avoided as this combination can result in additive sedative effects. This includes a variety of drug classes that cause drowsiness or decreased alertness, such as:

  • Other Antihistamines (e.g., diphenhydramine, cetirizine)
  • Sedatives and Tranquilizers
  • Benzodiazepines (e.g., alprazolam, lorazepam)
  • Opioids and Narcotic Pain Relievers
  • Muscle Relaxants
  • Certain Anticonvulsants (e.g., gabapentin, pregabalin)
  • Certain Antidepressants (e.g., amitriptyline)

Other Potential Interactions

Interaction Type Examples of Affected Products Potential Effect
Enzyme Inhibitors (e.g., Ketoconazole, Erythromycin) Ketoconazole (antifungal), Erythromycin (antibiotic) May theoretically increase azelastine plasma levels, although clinical studies with nasal spray have not consistently shown a clinically significant effect on cardiac rhythm.
Cannabis or CBD Products Cannabidiol (CBD) May enhance the risk of excessive sleepiness and decreased alertness due to additive CNS depression.

Patients should inform their healthcare provider of all prescription and over-the-counter medications, vitamins, and herbal supplements they are currently taking before starting azelastine hydrochloride.

Advertisements

Mechanism of Action

Azelastine functions primarily as a selective H1-receptor antagonist, binding to and stabilizing the inactive conformation of the G q-coupled histamine H1 receptors (H1R) located on various cell types, including endothelial cells and nerve endings. This competitive inhibition blocks the binding of endogenous histamine to H1R.

Antagonism of the H1R prevents the Gq protein-mediated intracellular cascade, which typically involves the activation of phospholipase C ( PLC), subsequent hydrolysis of phosphatidylinositol 4,5-bisphosphate ( PIP2) into inositol trisphosphate ( IP3) and diacylglycerol ( DAG), and the resulting increase in intracellular calcium ( Ca^2+). Downstream, this modulates systemic effects, including the reduction of capillary permeability and smooth muscle contraction.

Furthermore, azelastine exhibits a mast cell-stabilizing effect by inhibiting the release of key inflammatory mediators, including histamine, leukotrienes, and cytokines like TNF-alpha and IL-6 from mast cells and basophils. It also inhibits 5-lipoxygenase ( 5-LOX), an enzyme in the leukotriene synthesis pathway, contributing to the systemic modulation of inflammatory processes.

Advertisements

Dosage and Administration Information

How to Use Azelastine hydrochloride

This section outlines the standard administration protocols for Azelastine hydrochloride.


Official Routes and Dosing

Azelastine hydrochloride is formulated for topical administration via two primary routes: the intranasal route (nasal spray) and the topical ophthalmic route (eye drops). Dosing is structured around specific concentrations and frequencies.

Administration Route Standard Adult Dosing (Ages 12 and older) Frequency
Intranasal (Nasal Spray) 1 to 2 sprays per nostril Typically Twice Daily (BID) or Once Daily (QD)
Topical Ophthalmic (Eye Drops) 1 drop in each affected eye Typically Twice Daily (BID)

Administration Requirements

Correct use requires specific procedural steps to ensure proper delivery of the prescribed dose:

  • Device Priming: The nasal spray pump must be primed (e.g., 4 to 6 sprays or until a fine mist appears) before its initial use and must be re-primed if left unused for a period of several days.
  • Ophthalmic Use: Patients using the eye drop solution must remove soft contact lenses prior to administration and wait for a specified period (e.g., 10 to 15 minutes) before reinserting them.
  • Missed Dose: If a dose is missed, patients should skip the missed dose and continue with the next scheduled dose; the dose should not be doubled to compensate.
  • Population Rules: Specific, validated pediatric dosing regimens exist for children down to a certain minimum age (e.g., 5 or 6 years for the nasal spray), but no dose adjustment is typically required for older adults.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Azelastine Hydrochloride

Evidence for Use in Seasonal Allergic Rhinitis (SAR) Studies

The research for Azelastine hydrochloride was studied for Seasonal Allergic Rhinitis (SAR) symptoms in a body of short-term, randomized controlled trials (RCTs). These studies were used in research exploring how symptoms change over time during periods of increased allergen exposure. Researchers monitored outcomes linked to inflammatory or irritative states by measuring the Total Nasal Symptom Score (TNSS) and patient-reported outcomes describing perceived discomfort using the Rhinitis Quality of Life Questionnaire (RQLQ).

Research suggests patterns related to how symptoms evolved in the observed populations during the short trial period. However, the evidence base includes data from both monotherapy and combination products, which may limit the ability to fully isolate patterns linked to the single active compound. Follow-up durations were limited to just 2 to 4 weeks for primary outcome measurements.

Evidence for Use in Perennial Allergic Rhinitis (PAR) Studies

Research for Perennial Allergic Rhinitis (PAR), a condition characterized by fluctuating manifestations, is structured around Phase 3 randomized controlled trials. These trials were evaluated in studies examining symptom intensity over defined time intervals. Outcomes monitored included the Reflective Total Nasal Symptom Score (rTNSS) and outcomes reflecting daily functioning or activity level, such as sleep quality.

As with SAR, research exploring short-term symptom changes provides limited information for long-term outcomes. The evidence mainly reflects observations over the short-term treatment period, leaving data for long-term management in chronic conditions incomplete. Data for certain highly refractory subgroups remain insufficient.

Evidence in Special Populations and Uncertainties

The research has included a focus on distinct age groups. Studies were observed in adolescents (12 years and older), and specific clinical trials were evaluated in School-aged children (ages 5 to 11) with both SAR and PAR. This research contributes to the broader evidence landscape regarding symptom patterns in younger age groups.

Certainty remains low regarding long-term effects, as follow-up durations were limited in many key primary outcome measurements. Comparative evidence is lacking in some subgroups of interest, and the inclusion of combination products in the overall evidence landscape may introduce uncertainty when interpreting findings solely for Azelastine monotherapy.

Key Studies & References Azelastine Hydrochloride Nasal Spray (DailyMed, NIH/NLM) - FDA Regulatory Information

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Azelastine hydrochloride (FAQ)

Q: How quickly can I expect Azelastine hydrochloride to start working after the first use?

Studies on some formulations of Azelastine hydrochloride indicate a rapid onset of action. Official product information shows that relief for nasal allergy symptoms can begin as quickly as 15 minutes following the first administration.


Q: What is the reason for the common side effect of a bitter taste after using the nasal spray?

The bitter taste, known medically as dysgeusia, is a Very Common reported side effect. This is due to the inherent chemical nature of the active ingredient, azelastine hydrochloride, which is described in official labeling as having a distinctive bitter taste.


Q: How long is the relief expected to last after using Azelastine hydrochloride?

Azelastine hydrochloride is typically dosed to support symptom control over a long period. The prescribed use frequency (Once Daily or Twice Daily) is based on a duration of action that supports symptom management over 12 or 24 hours.


Q: Is it correct that proper spraying technique can help reduce the bitter taste side effect?

Yes, official patient instructions may describe techniques, such as head positioning, that have been used to minimize the drip into the throat, which is associated with the bitter taste. This is mentioned in labeling to help patients administer the medicine as intended.


Q: Is it true that Azelastine hydrochloride is available in different strengths (e.g., 0.10% and 0.15%)?

Yes, official regulatory documents confirm that Azelastine hydrochloride nasal spray is marketed in different concentrations. This includes formulations such as the 0.10% strength (137 mcg per spray) and the 0.15% strength (205.5 mcg per spray).


Q: Can Azelastine hydrochloride be associated with issues like increased heart rate or palpitations?

While generally rare, regulatory post-marketing surveillance reports have included instances of tachycardia (increased heart rate) and palpitations. These are classified as infrequent adverse reactions, and patients are advised to report any adverse effects to a healthcare provider.


Q: Does Azelastine hydrochloride contain a preservative, and are there patient concerns about this?

Many Azelastine hydrochloride formulations contain the preservative benzalkonium chloride. Official guidance for the ophthalmic (eye drop) formulation notes that this preservative can be absorbed by soft contact lenses, and that lenses may need to be removed prior to administration.


Q: Does the efficacy of Azelastine hydrochloride differ between seasonal allergic rhinitis and year-round (perennial) rhinitis?

Azelastine hydrochloride is formally indicated for the relief of symptoms associated with both Seasonal Allergic Rhinitis (SAR) and Perennial Allergic Rhinitis (PAR). This means its efficacy is established for both conditions, according to regulatory approvals.


Q: Are there any specific concerns about using Azelastine hydrochloride if a person has recently had nose surgery or a nose injury?

Regulatory documents note that subjects with a history of recent nasal surgery or trauma were typically excluded from clinical trials. This information helps healthcare professionals determine suitability for use.


Q: Is there any research evidence comparing the effectiveness of different Azelastine concentrations (e.g., 0.10% vs 0.15%)?

Yes, the approval of the higher-concentration 0.15% formulation was supported by clinical data. These studies contributed to the regulatory approval process for the 0.15% concentration.


Q: What is the reason that some Azelastine formulations contain ingredients for taste-masking?

Some Azelastine nasal spray products contain excipients (inactive ingredients) such as sucralose and sorbitol. These are included to give the solution a sweeter taste, which helps to mask the distinct bitterness of the active drug ingredient.


Q: Is Azelastine hydrochloride considered effective against a cough related to post-nasal drip?

Azelastine is indicated for the treatment of allergic rhinitis symptoms, including post-nasal drip (nasal discharge). Since the drug is not explicitly indicated for cough, official documents focus on its role in addressing symptoms like post-nasal drip, which is sometimes associated with cough.


Q: Can Azelastine hydrochloride be associated with side effects that involve the eyes, such as blurred vision?

Official product labeling lists both eye irritation and blurred vision as reported adverse reactions. These reactions are typically categorized as uncommon or rare events observed during clinical trials.


Q: Does Azelastine hydrochloride have a known effect on weight gain during long-term use?

Clinical trial data included in the official labeling for some formulations lists weight increase (weight gain) as a reported adverse reaction. This is often categorized as a rare or infrequent occurrence.


Q: Are there different brand names for Azelastine hydrochloride, and how do they compare in terms of formulation?

Yes, Azelastine hydrochloride is sold under different brand names, such as Astepro and Astelin. These branded products may differ in concentration (e.g., 0.10% vs. 0.15%) and the inclusion of specific taste-masking ingredients.


Q: What is the difference in active ingredients between Azelastine hydrochloride alone and combination sprays like Dymista?

Azelastine hydrochloride is an antihistamine. Combination nasal sprays that contain it, such as Dymista, typically include a second active ingredient, most commonly an intranasal corticosteroid like fluticasone propionate, to provide combined relief.


Q: Can use of the spray lead to crusting or sores inside the nose?

Official regulatory product labeling lists Epistaxis (nosebleed) and Nasal Mucosal Ulceration (sores or breaks in the nasal lining) as reported adverse reactions. These effects are generally uncommon or rare in incidence.


Q: What happens if Azelastine hydrochloride is accidentally sprayed into the eye?

The nasal spray is formulated and approved strictly for use in the nose. If accidental eye exposure occurs, official guidance indicates that healthcare providers or a poison control center may be contacted for specific instructions.


Q: Does Azelastine hydrochloride provide relief for both nasal congestion and other allergy symptoms?

Yes, official indications confirm that Azelastine hydrochloride is used for the temporary relief of a variety of upper respiratory allergy symptoms. This includes nasal congestion, runny nose, sneezing, and itchy nose.


Q: Can Azelastine hydrochloride nasal spray be used for non-allergic conditions like vasomotor rhinitis?

Yes, regulatory approvals for some prescription formulations of Azelastine hydrochloride extend to the treatment of vasomotor rhinitis, which is a type of non-allergic rhinitis.


Q: Is Azelastine hydrochloride safe for long-term daily use for perennial allergies?

Azelastine hydrochloride is formally indicated for perennial allergic rhinitis. However, it is noted in official documents that controlled clinical trials evaluating the long-term safety and effectiveness of the drug were generally limited to six weeks to six months of continuous use.


Q: What is the typical timeframe for seeing the full effects of Azelastine hydrochloride?

While rapid initial relief is common, controlled clinical trials often assess the drug's full efficacy over periods of two to four weeks. This indicates the timeframe used by regulators to measure the full treatment benefit and sustained symptom improvement.


Q: Are there any documented cases of Azelastine hydrochloride affecting a person's sense of smell or taste long-term?

The bitter taste (dysgeusia) is the most common taste-related side effect, and it is usually temporary. However, the complete loss of smell (anosmia) has been listed in official regulatory post-marketing reports as a rare adverse reaction.


Q: What are the official uses of Azelastine hydrochloride, according to regulatory bodies?

Official indications for Azelastine hydrochloride nasal spray include the treatment of symptoms associated with Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR), and Vasomotor Rhinitis. Some formulations are also indicated for ophthalmic (eye) allergy symptoms.


Q: Are there specific medical conditions that might require caution or a dosage adjustment when using Azelastine hydrochloride?

Official warnings primarily advise caution for conditions that may be worsened by the CNS depressant effects (drowsiness) of the drug. Dose adjustment is typically not required for older adults.


Q: Can Azelastine hydrochloride be used in combination with other classes of allergy medications?

Yes, combination therapy is an established treatment. Azelastine hydrochloride is co-formulated with an intranasal corticosteroid in certain approved products, demonstrating that combination use with different drug classes is possible.


Q: How does the mechanism of action of Azelastine differ from that of a mast cell stabilizer?

Azelastine hydrochloride is recognized for having a dual mechanism of action. It functions as both an H1-receptor antagonist (blocking the action of histamine) and has mast cell-stabilizing properties, which means it also inhibits the release of various other inflammatory chemicals.


Q: Can Azelastine hydrochloride interact with over-the-counter pain relievers or cold remedies?

Yes, an interaction may occur if the over-the-counter (OTC) medication is also a Central Nervous System (CNS) depressant. Combining Azelastine hydrochloride with any such OTC cold remedy or pain reliever can lead to an additive increase in drowsiness or reduced alertness.


Q: Is Azelastine hydrochloride nasal spray designed to be used daily or only when allergy symptoms occur?

According to official dosage instructions, the nasal spray is generally prescribed or directed to be used on a scheduled daily basis (Once Daily or Twice Daily). This is for the continuous management of symptoms rather than being used only as an occasional rescue treatment when symptoms occur.

Advertisements

How should Azelastine hydrochloride be stored and disposed of?

How to Store and Dispose of Azelastine Hydrochloride

Official regulatory guidelines require azelastine hydrochloride formulations (nasal spray and eye drops) to be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be protected from freezing and should be kept away from excess heat and moisture.

Container and Stability Constraints

The nasal spray container must be stored upright and kept tightly closed. The product must not be used past the labeled expiration date. For stability, the nasal spray should be discarded after the designated number of sprays, and unit-dose ophthalmic solutions have a specific post-opening use limit.

Child Safety and Disposal

It is mandatory to store all forms of azelastine hydrochloride out of the sight and reach of children in a safe, secured location. To dispose of unused or expired medicine, follow local guidance, typically by using a drug take-back program. If a take-back program is unavailable, the product should be mixed with an undesirable substance (e.g., dirt) and placed in a sealed container before discarding in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azelastine hydrochloride found in:

A-Z Index: